PharmaEngine, Inc. (TPEX:4162)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
57.00
+0.10 (0.18%)
At close: Mar 24, 2026

PharmaEngine Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
387.641,751274.65318.78426.03
Depreciation & Amortization
10.059.319.028.6110.26
Loss (Gain) From Sale of Investments
---5.53-45.46-0.83
Stock-Based Compensation
0.41.33.382.370.09
Provision & Write-off of Bad Debts
0.020-00.01-0.22
Other Operating Activities
-276.88344.77-33.31-54.79-81.69
Change in Accounts Receivable
1,582-1,670-13.830.13541.22
Change in Inventory
-11.5-12.4818.47-28.9419.31
Change in Accounts Payable
35.58---2.058.62
Change in Other Net Operating Assets
-0.2732.894.123.366.87
Operating Cash Flow
1,727456.73256.97202.01929.67
Operating Cash Flow Growth
278.09%77.74%27.21%-78.27%1335.36%
Capital Expenditures
-0.28-0.81-0.41-3.44-0.23
Sale (Purchase) of Intangibles
--0.6--0.5-
Investment in Securities
-266.18-114.67-854.48-183.98-105
Other Investing Activities
-0.190.55-0.59-0.2-1.77
Investing Cash Flow
-266.66-115.54-855.48-188.12-107
Long-Term Debt Repaid
-8.45-7.67-7.54-8-9.6
Net Debt Issued (Repaid)
-8.45-7.67-7.54-8-9.6
Repurchase of Common Stock
-----133.41
Common Dividends Paid
-861.92-215.44-287.19-387.71-363.99
Financing Cash Flow
-870.37-223.11-294.73-395.71-507
Foreign Exchange Rate Adjustments
-----0.75
Net Cash Flow
589.83118.08-893.24-381.81314.93
Free Cash Flow
1,727455.92256.56198.57929.44
Free Cash Flow Growth
278.70%77.71%29.20%-78.64%1335.01%
Free Cash Flow Margin
189.44%18.07%33.42%30.34%141.94%
Free Cash Flow Per Share
11.983.171.781.386.42
Cash Interest Paid
0.140.180.310.080.21
Cash Income Tax Paid
396.2861.3792.35124.42200.65
Levered Free Cash Flow
1,617-19.65159.87105.29723.9
Unlevered Free Cash Flow
1,617-19.54160.06105.34724.04
Change in Working Capital
1,606-1,6508.76-27.51576.02
Source: S&P Global Market Intelligence. Standard template. Financial Sources.